Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
2(29%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
14%
Ph phase_2
2
29%
Ph early_phase_1
1
14%
Ph phase_1
3
43%

Phase Distribution

4

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Early Phase 1First-in-human
1(14.3%)
Phase 1Safety & dosage
3(42.9%)
Phase 2Efficacy & side effects
2(28.6%)
N/ANon-phased studies
1(14.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

7

all time

Status Distribution
Active(2)
Completed(4)
Other(1)

Detailed Status

Completed4
Active, not recruiting1
unknown1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
2
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (14.3%)
Phase 13 (42.9%)
Phase 22 (28.6%)
N/A1 (14.3%)

Trials by Status

active_not_recruiting114%
unknown114%
recruiting114%
completed457%

Recent Activity

2 active trials
Showing 5 of 7
completedearly_phase_1

Human Cerebral Blood Flow Regulation

NCT04265053
active_not_recruitingphase_2

Microbiota Transplant Therapy for Children With Both Autism Spectrum Disorder and Gastrointestinal Disorders

NCT06503978
recruitingphase_2

Microbiota Transfer Therapy for Children and Adults With Both Pitt Hopkins Syndrome and Gastrointestinal Disorders

NCT06321796
unknownnot_applicable

Efficacy and Speed of Action of a Product to Control Gastric Hydration and Gastroesophageal Reflux

NCT05060744
completedphase_1

A Study to Evaluate a New Tablet Formulation of Lu AG06466 in Healthy Participants

NCT05028673
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT04265053Early Phase 1

Human Cerebral Blood Flow Regulation

Completed
NCT06503978Phase 2

Microbiota Transplant Therapy for Children With Both Autism Spectrum Disorder and Gastrointestinal Disorders

Active Not Recruiting
NCT06321796Phase 2

Microbiota Transfer Therapy for Children and Adults With Both Pitt Hopkins Syndrome and Gastrointestinal Disorders

Recruiting
NCT05060744Not Applicable

Efficacy and Speed of Action of a Product to Control Gastric Hydration and Gastroesophageal Reflux

Unknown
NCT05028673Phase 1

A Study to Evaluate a New Tablet Formulation of Lu AG06466 in Healthy Participants

Completed
NCT00944307Phase 1

Effect of Antacids on the Pharmacokinetics of Raltegravir

Completed
NCT02097329Phase 1

Study Of Three Different Stomach Acid Reducing Agents When Given With Palbociclib (PD-0332991) And Food

Completed

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7